Blood-based biomarkers measuring systemic inflammatory response such as the neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) were also evaluated as predictors of cancer outcomes in NMIBC. Here, CRP is linked to cancer.